Study summary · research use only
In vitro effect of short peptides on expression of interleukin-2 gene in splenocytes
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study examined splenocytes from CBA mice in vitro, testing the synthetic peptides Vilon (Lys-Glu), Epithalon (Ala-Glu-Asp-Gly), and Cortagen (Ala-Glu-Asp-Pro) on interleukin-2 gene expression. All three peptides activated interleukin-2 mRNA synthesis without added inducers, with intensity depending on peptide type, concentration, and treatment duration. Vilon and Epithalon produced the most pronounced responses, while Cortagen produced a less pronounced response on interleukin-2 mRNA synthesis.
Abstract
Synthetic peptides Vilon (Lys-Glu), Epithalon (Ala-Glu-Asp-Gly), and Cortagen (Ala-Glu-Asp-Pro) in vitro activated interleukin-2 mRNA synthesis in splenocytes from CBA mice in the absence of specific inductors. The intensity of interleukin-2 mRNA synthesis in splenocytes depended on the type, concentration, and duration of treatment with the peptides. Vilon and Epithalon were most potent, while Cortagen produced a less pronounced effect on interleukin-2 mRNA synthesis.
pepmg summarizes the peer-reviewed literature and links to every source. It sells nothing and ships nothing. Where an FDA label, a peer-reviewed study or a clinical-trial registry entry (labeled trial registry, not peer-reviewed) has published a dose, pepmg reports it with the source named; it gives no personalized recommendations and no administration technique. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.